Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Added to Ropivacaine for Ultrasound-Guided Nerve Blocks in Arthroscopic Shoulder Surgery
ChiCTR-IPR-16009843Phase 4Not yet recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Nov 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Rotator cuff deficiency (RCD) comparing D group: ropivacaine 0.35% with E group: ropivacaine 0.35% + dexmedetomidine 1 μg/kg (2 arms). Primary endpoints: Blood pressure, Heart rate and 4 more. Planned start Nov 2016; status: not yet recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
Rotator cuff deficiency (RCD)
Beyond the preview
Go deeper on ChiCTR-IPR-16009843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009843.